Setlakin Kit
Product Images NDC 16714-366

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Setlakin (NDC 16714-366). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (Image 01)

An instructional diagram showing two blister strips of Setlakin kit tablets, each with labeled days of the week and weeks of administration. Each strip contains pink active tablets arranged in a 7-day weekly format labeled for tracking in weeks 1 to 8. Storage instructions indicate keeping the product at controlled room temperature (20° to 25°C).*

FDA Label Image

Image-02 (Image 02)

An instructional diagram titled 'Figure B' depicting a monthly tablet blister strip regimen for Setlakin (Levonorgestrel and Ethinyl Estradiol Tablets, 0.15 mg / 0.03 mg). It shows four rows of pink (active) tablets for weeks 9-12 and one row of white (inactive) tablets for week 13, arranged by days Sunday through Saturday, with guidance to perform a monthly self-breast exam and storage instructions at controlled room temperature.*

FDA Label Image

Image-03 (Image 03)

Chemical structure of Levonorgestrel shown as a molecular diagram, including its molecular formula C21H28O2 and molecular weight 312.4. This structure depicts the arrangement of carbon, hydrogen, and oxygen atoms in the active ingredient Levonorgestrel.*

FDA Label Image

Image-04 (Image 04)

Chemical structure diagram of Ethinyl Estradiol, showing its molecular formula C20H24O2 and molecular weight 296.4.*

FDA Label Image

Image-05 (Image 05)

Label image showing the NorthStar Rx logo and manufacturing information for SETLAKIN, a kit containing Levonorgestrel and Ethinyl Estradiol. Manufactured for Northstar Rx LLC, Memphis, TN, and by Novast Laboratories Ltd. in Nantong, China. Includes a toll-free phone number for contact.*

FDA Label Image

Image-06 (Image 06)

An instructional chart illustrating pregnancy rates per 100 women in one year correlated with various birth control methods. The vertical scale shows fewer pregnancies at the top (fewer than 1) and more pregnancies at the bottom (85 or more). Methods listed include implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal rings, condoms, diaphragm, abstinence during fertile days, spermicide, withdrawal, and no birth control.*

FDA Label Image

Image-07 (Image 07)

Setlakin kit containing Levonorgestrel and Ethinyl Estradiol 0.15 mg/0.03 mg tablets shown in three blister strips labeled by week. Pink active tablets are arranged for weeks 1-12, with white inactive tablets in week 13. Each strip is organized by days Sunday through Saturday with instructions to perform monthly breast exams and storage conditions at 20° to 25°C.*

FDA Label Image

Image-08 (Image 08)

A dosing schedule illustration for Setlakin tablets (Levonorgestrel and Ethinyl Estradiol 0.15 mg/0.03 mg) showing a weekly layout of circular tablets from Sunday to Saturday for four weeks. A hand points to the first tablet to be taken on Sunday, indicating the start of Week 1. The diagram includes storage instructions to keep the product at 20° to 25°C (68° to 77°F) and a reminder for monthly self breast exams.*

FDA Label Image

Image-09 (Image 09)

This image shows manufacturing information for the prescription drug kit SETLAKIN, containing Levonorgestrel and Ethinyl Estradiol. It states the product is manufactured for Northstar Rx LLC in Memphis, TN, and by Novast Laboratories Ltd. in Nantong, China. A toll-free contact number is also provided.*

FDA Label Image

Image-10 (Image 10)

Packaging label for Setlakin kit containing Levonorgestrel and Ethinyl Estradiol tablets, USP, 0.15 mg/0.03 mg. The kit includes three extended-cycle tablet dispensers with a total of 91 tablets. Labeler is Northstar Rx LLC. The label features dosage information, storage instructions, and a hibiscus flower graphic on a white background.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.